Home > Boards > Canadian > Biotechs > Alda Pharmaceuticals (TSXV:APH)

Nanotech Systems apppoints Owen as Chief Executive Officer,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Grace4 Member Profile Grace4  
Thursday, July 26, 2012 1:17:52 PM
Re: Grace4 post# 4068 Post # of 4073 
Nanotech Systems apppoints Owen as Chief Executive Officer, effective May 1, 2012.
(RTTNews) - Nanotech Systems, Inc. said Tuesday that it has appointed Dr. Terrance Owen as Chief Executive Officer, effective May 1, 2012.

Dr. Owen is the co-founder and has been the President and CEO of ALDA Pharmaceuticals Corp., which has developed novel, patented, OTC infection control therapeutics for topical use, since 2000. From 1980 to 2002, he was the President of Helix Biotech , which provided DNA testing services for paternity, immigration and forensic cases across Canada. From 1995 to 1998, he was also the President of Helix BioPharma Corp.

Dr. Owen has 25 years of executive experience with publicly-traded life sciences companies in Canada and the US. He will be responsible for maintaining Nanotech's listing on the Frankfurt Stock Exchange, which is eliminating its First Quotation Board and requiring companies to meet the Entry Standard listing requirements by December 15,2012.

by RTT Staff Writer
http://www.rttnews.com/1929544/nanotech-systems-appoints-terrance-owen-as-ceo.aspx?type=qf&utm_source=google&utm_campaign=sitemap


Alda Pharmaceuticals (TSXV:APH) Stock Trading Info:
Alda Pharmaceuticals TSXV:APH Stock Quote Alda Pharmaceuticals TSXV:APH Stock Charts Alda Pharmaceuticals TSXV:APH Financial
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist